Double Blind Placebo Controlled Multicenter Trial for Prevention of IMT Progression in the Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage With Cilostazol and Probucol
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Cilostazol (Primary) ; Aspirin; Probucol
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PICASSO-IMT
- 23 Dec 2015 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 23 Dec 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Sep 2016 as reported by ClinicalTrials.gov.
- 02 Jul 2015 New trial record